McKay, G. E., Coromilas, A., Liu, L., Shaw, K. S., Murphy, M., Punyamurthy, N., Soltero, K. M. S., Damsky, W., Wanat, K. A., Charrow, A. P., Rosenbach, M., Caplan, A., LaSenna, C. E., Arkin, L., & Shields, B. E. (2025). Interleukin‐12/23 and Interleukin‐23 Inhibitors for the Treatment of Cutaneous Crohn’s Disease: A Case Series From a Multi‐Institutional Registry. JEADV Clinical Practice. Portico. https://doi.org/10.1002/jvc2.615

Vats, K., Tian, H., Singh, K., Tyurina, Y. Y., Sparvero, L. J., Tyurin, V. A., Kruglov, O., Chang, A., Wang, J., Green, F., Samovich, S. N., Zhang, J., Chattopadhyay, A., Murray, N., Shah, V. K., Mathers, A. R., Chandran, U. R., Pilewski, J. M., Kellum, J. A., … Bunimovich, Y. L. (2024). Ferroptosis of select skin epithelial cells initiates and maintains chronic systemic immune-mediated psoriatic disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci183219

Fahmy, L. M., Schreidah, C. M., Lapolla, B. A., Magro, C. M., & Geskin, L. J. (2023). Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis. JAAD Case Reports, 41, 85–89. https://doi.org/10.1016/j.jdcr.2023.08.049

Fahmy, L. M., Kwinta, B. D., Schreidah, C. M., Ferris, L. K., & Geskin, L. J. (2022). Topical Mechlorethamine for the Treatment of Psoriasis: A Report of Two Cases and Literature Review. Dermatology and Therapy, 13(2), 617–627. https://doi.org/10.1007/s13555-022-00871-2